“Exogenous treatment with an inflammatory cytokine, Tumor Necrosis Factor Alpha, increases invasiveness in highly and weakly metastatic breast cancer cells MDA-MB-231 and MCF-7”

Publication Date

July 2022

Document Type

Presentation

Start Date

21-7-2022 10:00 AM

This document is currently not available here.

Share

COinS
 
Jul 21st, 10:00 AM

“Exogenous treatment with an inflammatory cytokine, Tumor Necrosis Factor Alpha, increases invasiveness in highly and weakly metastatic breast cancer cells MDA-MB-231 and MCF-7”